MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    Quality of Life and Depression in Patients with and without Idiopathic Parkinson’s Disease without Dementia.

    S. Ospina Otalvaro, C. Alberto Hurtado-González, J. Felipe Ayala-Rico, P. Andrea Gutiérrez-Leni, A. Lucumi-Moreno, S. Cárdenas-Zuñiga, M. Cañas-Lucendo, D. Reyes-Torres, S. Ordoñez-Cure, A. Cubides-Munévar, J. Marmolejo-Florez (Cali, Colombia)

    Objective: To identify the impact of depression on QoL in a group of patients with IPDWD. Background: The Quality of Life (QoL) in patients with…
  • 2025 International Congress

    Biological Characteristics of Individuals with RBD: A Multicenter Prospective Longitudinal Cohort

    J. Feuerstein, E. Brown, L. Chahine, C. Gochanour, D. Lafontant, M. Marshall, T. Simuni, D. Weintraub (Aurora, USA)

    Objective: Examine baseline clinical and biological characteristics of participants with polysomnography-confirmed REM Sleep Behavior Disorder (RBD). Background: RBD is an early manifestation of underlying synucleinopathy…
  • 2025 International Congress

    A shortened MDS-UPDRS Patient-based item bank increases sensitivity for predicting dopaminergic therapy initiation: A Longitudinal IRT Analysis in early PD

    S. Luo, L. Yu, G. Stebbins, T. Mestre, C. Goetz (Durham, USA)

    Objective: To predict the need for dopaminergic therapy initiation in early PD patients, we sought to identify a short item bank focused on the Movement…
  • 2025 International Congress

    The Effects of Sex and Race on the Quality of Life of Parkinson’s Patients in Hawai’i

    R. Shuman, E. Krening, M. Bruno, F. Gao, K. Thai, M. Faouzi, GW. Ross (Hawaii, USA)

    Objective: To explore the intersectionality between sex and race in the Parkinson’s Disease Questionnaire-8 (PDQ-8) among patients with Parkinson’s Disease in Hawai’i. Background: Parkinson’s disease…
  • 2025 International Congress

    Temporal Trends in Parkinson’s Disease Related Mortality from 1999-2023: A National Analysis pre and post COVID

    N. Bujala, R. Shi, J. Javeid, Z. Xu, F. Yu (New York, USA)

    Objective: To examine the trends and impact of COVID-19 on Parkinson’s disease (PD) mortality stratified by gender, race and region among older adults in the…
  • 2025 International Congress

    Morbidity and Mortality Associated with Aspiration Pneumonia: Nationwide Trends in Inpatient Therapy Utilization in Parkinson’s Disease Hospitalization

    T. Mehta, H. Kamo, R. Burke, M. Rem, M. Okun, C. Hess (Gainesville, USA)

    Objective: To characterize inpatient therapy utilization and the impact of aspiration pneumonia (AP) on morbidity, mortality, and outcomes in hospitalized Parkinson’s disease (PD) patients. Background:…
  • 2025 International Congress

    Parkinson’s disease GWAS-linked SNCA carriers show slower non-motor and cognitive progression

    DX. Deng, LT. Tan, TEK. Tan (singapore, Singapore)

    Objective: To investigate the disease progression between SNCA rs6826785 C allele carriers and noncarriers over 5 years. Background: A genome-wide association study-linked variant (SNCA rs6826785) was shown to have…
  • 2025 International Congress

    Parkinson’s Disease Epidemiology and Treatment Characteristics in Australia

    M. Lubomski, A. Evans, R. Mackinnon, R. Rossiter, M. Falster, M. Kouhkamari, T. Suresh, A. Mikolaizak, J. Waern (St Leonards, Australia)

    Objective: This project aims to identify epidemiological characteristics specific to people diagnosed with Parkinson’s disease (PD) treated with PD medications or device-aided therapies in New…
  • 2025 International Congress

    Bias in Pharmacoepidemiological Studies of Parkinson’s Disease Prescribing Patterns: A Systematic Review

    K. Orayj (Abha, Saudi Arabia)

    Objective: This systematic review aims to identify and evaluate reported biases in pharmacoepidemiological studies on nonrandomized prescribing patterns, drug utilization, or treatment trends in PD.…
  • 2025 International Congress

    A Study Of Axial Postural Abnormality In Parkinson`s

    V. Rama Raju (Hyderabad, India)

    Objective: APA involves distinct modes plus sequence patterns and proven predictors for every APA remains mystery. The goal is to probe the progress of APA…
  • « Previous Page
  • 1
  • …
  • 27
  • 28
  • 29
  • 30
  • 31
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley